Background: Infectious diseases are a leading cause of morbidity and mortality worldwide.
As of 2018, the total world population of children Objective: The purpose of the present …

Tremendous efforts are undertaken to quickly develop COVID‐19 vaccines that protect
vulnerable individuals from severe disease and thereby limit the health and socioeconomic …

Severe acute respiratory syndrome coronavirus 2 related disease (COVID-19) is now
responsible for one of the most challenging and concerning pandemics. By August 2020 …

Vaccines are safe and effective in protecting individuals and populations against infectious
diseases. New vaccines are evaluated by a long-standing, rigorous, and transparent …

Aim To document the decline in vaccination coverage in the first months of 2020 as an
indirect effect of the COVID‐19 pandemic. Methods We performed a literature review in …

As of October 2021, SARS-CoV-2 infections were reported among 512,613 children and
adolescents in Israel (~ 33% of all COVID-19 cases). The 5–11-year age group accounted …

Since the beginning in December 2019, the SARS-CoV-2 outbreak appeared to affect
mostly the adult population, sparing the vast majority of children who only showed mild …

Primary care providers play key roles in ensuring that children and the community receive
vaccines on time. Sometimes, this role includes the task of reassuring parents who are …

Strategies for the use of COVID‐19 vaccines in children and young adults (in particular
university students) are hotly debated and important to optimize. As of late August 2021 …

Children could benefit both directly and indirectly from vaccination. In light of the safety and
immunogenicity results from recent adult COVID-19 vaccine clinical trials, children should …